Skip to main content
Premium Trial:

Request an Annual Quote

Perlegen, Unilever Pen Partnership to Develop Consumer Products

NEW YORK, Feb. 20 - Perlegen Sciences has signed a multi-year research collaboration with Unilever that will use the Affymetrix spinoff's whole genome-association technologies to develop new consumer products.

Terms of the agreement, announced today, call for Perlegen to pocket research funding, "research success payments," and royalties on consumer product sales. In addition, Perlegen will retain rights to develop potential therapeutic products based on the research results.


Unilever, founded in 1930, sells a variety of consumer goods from tea bags and ice cream to soaps and candies. It was not immediately clear what kinds of products the collaboration would develop, or in what way Perlegen's technology would be used. Officials at both companies did not immediately return telephone calls seeking comment.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.